J B Chemicals & Pharmaceuticals Ltd Share Price Today - J B Chemicals & Pharmaceuticals Ltd Stock Price Live NSE/BSE

J B Chemicals & Pharmaceuticals Ltd

NSE: JBCHEPHARM BSE: 506943

₹2064.40

(0.37%)

Thu, 02 Apr 2026, 07:44 pm

MTF 5xInvest in J B Chemicals & Pharmaceuticals Ltd with 5x Leverage Buy with MTF

Market Cap331.26B

PE Ratio43.51

Dividend0.96

Health Technology

Pharmaceuticals: Major

24.5K

J B Chemicals & Pharmaceuticals Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
32281.13
Net Profit
659.58
P/B
7.36
Sector P/E
31.44
P/E
38.29
EV/EBITDA
23.50
Debt/Equity (Industry)
0.23
Interest Cover (Industry)
9.71
ROCE (Industry)
13
RONW (Industry)
12.31
ROE
20.75
ROCE
26.42
Debt/Equity
0.06
EPS (TTM)
46.95
Dividend Yield
0.75
Book Value
237.06
Interest Cover
76.65

Analysis

all

Pros

Dividends per share have increased over the past 10 years.
Dividends paid are well covered by earnings (6.7x coverage).
Dividends after 3 years are expected to be well covered by earnings (5.8x coverage).
J. B. Chemicals & Pharmaceuticals's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
J. B. Chemicals & Pharmaceuticals's earnings growth is expected to exceed the low risk savings rate of 7.2%.

Cons

Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
J. B. Chemicals & Pharmaceuticals's dividend is below the markets top 25% of dividend payers in India (3.08%).
Cash flow for J. B. Chemicals & Pharmaceuticals is expected to increase but not above the 50% threshold in 2 years time.
J. B. Chemicals & Pharmaceuticals's earnings are expected to grow by 12.8% yearly, however this is not considered high growth (20% yearly).
J. B. Chemicals & Pharmaceuticals's earnings growth is positive but not above the India market average.

Financials

Ratios

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	47.55	47.56	47.73	47.84	53.66
FII	14.88	15.30	17.77	18.31	14.66
DII	23.36	22.83	19.63	18.72	16.41
Public	14.22	14.30	14.88	15.13	15.27
Government	0.00	0	0	0	0.00

Technical Analysis

RSI

37.37

MACD

5.27

50 DMA

1993.54

200 DMA

1801.80

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	2519.80	2298.80	2181.60	2077.80	1960.60	1856.80	1635.80
Fibonacci	2298.80	2214.38	2162.22	2077.80	1993.38	1941.22	1856.80
Camarilla	2125.18	2104.92	2084.66	2077.80	2044.14	2023.88	2003.63

Pivots Level: Classic

+442

2519.80

+221

2298.80

+103.80

2181.60

2077.80

Pivot Point

LTP: 1961.10

-117.20

1960.60

-221

1856.80

-442

1635.80

Moving Average

SMAEMA

Period

Value

10-EMA
2049.55
20-EMA
2056.50
30-EMA
2042.47
50-EMA
2004.66
100-EMA
1927.73
200-EMA
1847.19

Announcement Date	Purpose	Action	Ex Date
27 Mar 2026	egm
05 Feb 2026	dividend	₹12.70 Dividend /Share	11 Feb 2026
16 Jan 2026	board-meetings	Quarterly Results
11 Jan 2026	dividend	Interim Dividend - Rs. - 12.7	11 Feb 2026
11 Nov 2025	board-meetings	Quarterly Results, Half Yearly Results
11 Jul 2025	agm
30 Jun 2025	dividend	Final Dividend - Rs. - 7	30 Jul 2025
14 May 2025	dividend	₹7.00 Dividend /Share	30 Jul 2025
04 Feb 2025	dividend	₹8.50 Dividend /Share	08 Feb 2025
08 Jan 2025	dividend	Interim Dividend - Rs. - 8.5	08 Feb 2025

J B Chemicals & Pharmaceuticals Ltd

Divis Laboratories Ltd

Lupin Ltd

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd

Dr Reddys Laboratories Ltd

J B Chemicals & Pharmaceuticals Ltd About

J B Chemicals & Pharmaceuticals is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and Active Pharmaceutical Ingredients (APIs).

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1976

Headquarters

CEO

Arun Duggal

Employees

Contact

Website

http://www.jbpharma.com

investorelations@jbpharma.com; secretarial@jbpharm

Phone

91-022-2482 2222/2493 0918

Location

Neelam Centre 4th Floor, B-Wing Hind Cycle Road Worli, Mumbai, Maharashtra, 400030

Year	History
No Result Found

Client Name	Order Side	QTY	Avg Price	Date
KOTAK MAHINDRA MUTUAL FUND	Buy	1230769	1625	27 Mar 2025
TAU INVESTMENT HOLDINGS PTE LIMITED	Sell	2245786	1625.34	27 Mar 2025
TAU INVESTMENT HOLDINGS PTE LIMITED	Sell	2245787	1625	27 Mar 2025
TAU INVESTMENT HOLDINGS PTE LIMITED	Sell	2245786	1625	27 Mar 2025
TAU INVESTMENT HOLDINGS PTE LIMITED	Sell	2245786	1625.01	27 Mar 2025
THE VANGUARD GROUP INC A/C VANGUARD EMERG. MKTS STOCK INDEXFD A SERIES OF V I E I F	Buy	706756	1121.89	18 Sept 2020
ASHISH DHAWAN	Sell	472096	289.54	02 Nov 2017
ICICI LOMBARD GENERAL INSURANCE CO LIMITED	Buy	2000000	288	01 Nov 2017
ASHISH DHAWAN	Sell	1952206	288.12	01 Nov 2017
KOTAK MAHINDRA ASSET MANAGEMENT CO LTD (SSV2 -SELL CODE) PM	Sell	600659	280	25 Oct 2017

J B Chemicals & Pharmaceuticals Ltd News

J.B. Chemicals CEO Nikhil Chopra Steps Down

J.B. Chemicals & Pharmaceuticals announces cessation of Nikhil Chopra as CEO and Key Managerial Personnel effective March 31, 2026, following his resignation for personal reasons and new opportunities.

01 Apr 2026

companies

JB Chemicals Publishes Shareholder Meeting Notice

J.B. Chemicals published newspaper advertisement for equity shareholder meeting on April 28, 2026, convened pursuant to NCLT order dated March 23, 2026 for Torrent Pharmaceuticals merger approval.

28 Mar 2026

companies

JB Chemicals Gets NCLT Corrigendum on Torrent Merger

J.B. Chemicals & Pharmaceuticals informed exchanges about NCLT Ahmedabad Bench issuing a corrigendum order dated March 24, 2026, regarding its proposed amalgamation with Torrent Pharmaceuticals Limited.

26 Mar 2026

companies

J.B. Chemicals Appoints Five Directors via Postal Ballot

J.B. Chemicals & Pharmaceuticals shareholders approved five director appointments through postal ballot on March 24, 2026, including Aman Mehta as Managing Director with 99.85% approval rate.

25 Mar 2026

companies

J.B. Chemicals Approves Five Director Appointments

J.B. Chemicals & Pharmaceuticals shareholders approved five director appointments through postal ballot on March 24, 2026, including Aman Mehta as Managing Director with 99.85% votes in favor.

24 Mar 2026

companies

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800